Connect with us

BUSINESS

BetterLife Pharma Inc (OTCMKTS: BETRF) Announced it had Enrolled Its First Patient to Test Its Proprietary Inhaled Interferon Alpha-2b Product, AP-003

Published

on

BetterLife Pharma Inc (OTCMKTS: BETRF) has announced that it has registered its first patient for the Phase 1 part of Phase 1-2 randomized placebo-controlled in COVID-19 patients. The trial is initiated to test the group’s proprietary inhaled interferon alpha-2b product, AP-003.

Team and trial center are leaders in performing COVID-19 trials in Chile

The team of experts and the center are leaders in performing COVID-19 related clinical trials in Chile. The Chief Executive Officer of BetterLife Pharma Inc, Dr. Ahmad Doroudian, went on record and stated that his team is excited to carry out the trial of AP-003 in patients who are tested positive for the coronavirus. Dr. Doroudian informed that the group has partnered with Escuela de Medicina (School of Medicine) at the Pontificia Universidad Católica de Chile to test its proprietary inhaled interferon Alpha-2b product, AP-003. 

It is learned that the test trials of AP-003 are carried out by Altum Pharmaceuticals Inc, which is a 100% owned subsidy of BetterLife Pharma Inc., in partnership with Pontificia Universidad Católica de Chile. 

Result from oriented and non-invasive treatment like AP-003 to treat COVID-19 is the need of the hour

The Study Director of the IN2COVID trial also serves as Associate Professor and Head of Pediatric Immunology, Allergy, and Rheumatology at the School of Medicine of Pontificia Universidad Católica de Chile, Dr. Arturo Borzutzky, commented on the development. He shared that he is pleased to join hands with Altum Pharmaceuticals Inc to bring the AP-003 to patients who tested positive for the coronavirus. 

Dr. Borzutzky added that there are many reasons for the need to have a result-oriented, easy to implement, and non-invasive treatment, like AP-003, to treat patients diagnosed with coronavirus. Listing out the reasons, he said that one of them is the emergence and rampant spread of the SARS-CoV-2 variant. Another reason, according to him, is the sheer lack of scientific knowledge and medical awareness of the period the vaccines can work to protect an individual against the covid virus. Lastly, Dr. Borzutzky strongly believes that the accurate picture of breakthrough infections that vaccinated patients acquire is unclear. Thus, he reiterates that the need of the hour is result-oriented and non-invasive treatment like AP-003 to treat COVID-19. 

BetterLife Pharma Inc is an upcoming biotechnology company involved in developing and commercializing next-generation psychedelic products used to treat a range of mental disorders.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

BUSINESS

Cyberlux Corp (OTCMKTS: CYBL) Gives Update on Its Accomplishments for September 2021

Published

on

Cyberlux Corp (OTCMKTS: CYBL) has announced its most essential accomplishments on September 2021. A statement given by the company’s CEO Mark Schmidt reveals its achievements.

Achievements Cyberlux made in September 

One such achievement is the hiring of a new General Manager and Executive Vice President for Cyberlux’s FlightEye Drone Solutions. Larson Isley, who will take on this role, has vast experience as a Consulting Scientist and Guidance System Expert.

The company also introduced its FlightGDN platform to take advantage of UAS and its future capabilities. FlightGDN is a technology platform focussed on supporting high-tech military-grade UAS solution packages and products. It incorporates Cyberlux technologies and also uses third party technology such as VR/AR perception technologies, LiDAR mapping, infrared night vision and, LED lighting. The company also refreshed its website on September 30.

Cyberlux completed the acquisition of CTMC Drone Solutions, LLC, which will make up its drone technology platform. The company made the transaction with a series of cash payments, cashless warrants and shares of common stock. Cyberlux plans to use this same structure with its future acquisitions.

The company also partnered with Strike Group, LLC to promote the contracting and adoption of Cyberlux Infrastructure products such as solar power solutions and LED street lighting. It was also to promote products by Flight Eye Drone Solutions.

Yahoo has also identified Cyberlux as one of the ten best Micro-cap stocks for investors.

Cyberlux’s plans 

Cyberlux is making plans to announce the hiring of a new staff member who will be instrumental in improving its Unmanned Aircraft Systems Business. The new hire is said to have significant reach with U.S agencies.

The company will also announce a new acquisition. This acquisition will help Cyberlux penetrate European and U.S markets. Another Cyberlux platform acquisition will be closed by the end of October.

Meanwhile, Cyberlux will continue to execute its Alpha growth plan. The plan consists of three objectives. The first is to accelerate growth acquisitions, aggressive strategies, and partnerships. The second objective is to focus on the target market with DoD products and new technology. The final aim is to get OTC Pink Current Information Status to gain velocity.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Puget Technologies Inc (OTCMKTS: PUGE) Formally Announces That The Group Has Ventured Into The Real Estate Market and The Group Names Carlos H. Arce, Esq. As Its Chief Legal & Compliance Officer

Published

on

Puget Technologies Inc (OTCMKTS: PUGE) has hit the headlines yet again. The group made an official announcement that it has forayed into the real estate industry.

The group has inked a Letter of Interest for the acquisition

Sources have confirmed that Puget Technologies Inc has inked a LOI to allow the group to take over a company in the real estate sector. The acquired group will double up as a space providing facilities that are necessary for medical practitioners.

Furthermore, it is understood that a corporate house named Care Suites LLC was established in Delaware in 2019. The group aims to adopt the innovative approach and co-work. By doing so, medical practitioners can effortlessly and quickly switch to individual practice by taking advantage of facilities offered by CareSuitesTM.

To make the process user-friendly, CareSuites has committed to providing medical practitioners, health care workers, and staff with the facilities, infrastructure, and equipment required in private practice. A source from the company shared that this is one of the most affordable ways medical practitioners should take advantage of.

Puget Technologies Inc is granted the right to negotiate acquisition terms

Puget Technologies Inc is granted the right to negotiate acquisition terms with CareSuites. The latter gives the former the requests till March 12, 2022. Under the terms of the acquisition, securities of CareSuites’ will be exchanged for shares of Class B Convertible Preferred Stock. If all works well, CareSuites will become a 100% owned member of Puget Technologies Inc companies. A source following the developments shared that Puget Technologies Inc is anticipating sealing the deal at the earliest.

Puget Technologies Inc has a new addition to its management team 

Puget Technologies Inc, in other news, has informed that the group has taken on board Carlos H. Arce, Esq. In a statement, the company announced that Arce would serve as Chief Legal & Compliance Officer. The new appointment stands effective from October 5, 2021. On the new job role, Arce expressed happiness in being associated with the leaders in the industry.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

VOLKSWAGEN GROUP Common Stock (OTCMKTS: VLKPF) Bags TU Wien Prize, Financial Services of the Group inks joint venture with LM FROTAS in Brazil and Company Adds 70,000 New Clients with Best-Selling ID.3 in Its Debut Year

Published

on

VOLKSWAGEN GROUP Common Stock (OTCMKTS: VLKPF) is in a celebration mood. The group has added yet another feather to its cap.

VOLKSWAGEN GROUP Common Stock awarded for developing the modular electric drive matrix (MEB)

VOLKSWAGEN GROUP Common Stock was recently awarded to develop the modular electric drive matrix (MEB). For this effort, the 22nd Porsche Prize was conferred on the automobile giant. On behalf of the company, Thomas Ulbrich, a member of the Volkswagen brand Board of Management, Technical Development division, accepted the recognition.

MEB is an all-new era of mobility

The modular electric drive matrix, also known as MEB, redefines mobility. With the MEB, the group has achieved the aim of introducing a new generation of electric drive, which drastically brings down the e-mobility cost and, at the same time, works to achieve zero-emission mobility.

The electric drive matrix is engineering at its best 

Dr. Bernhard Geringer, who serves as a member of the board of the Institute for Powertrains and Automotive Technology at TU Wien, stated that the electric drive matrix is engineering at its best. Dr. Geringer added that the flexibility, design solutions, and application would shape the future of electric mobility.

Volkswagen Financial Services enters into a joint venture with LM FORTAS in Brazil

To thrive in the market in Brazil, Volkswagen Financial Services recently entered into a joint venture with fleet provider LM FORTAS in Brazil. The agenda of the joint venture is to expand the fleet business in Brazil. While Volkswagen Financial Services holds a 60% stake in the joint venture, LM FORTAS owns the remaining 40%.

The Managing Director of Volkswagen Financial Services in Brazil, Jörg Pape, said that the group is working towards becoming the world’s largest fleet provider. Pape added that the sector offers a lot of potentials to grow. Confident of the partnership, he stated that the overall market volumes will be higher in 2026.

In other news related to VOLKSWAGEN GROUP Common Stock, it has come to light that the group has added to its client base, 70,000 new customers. The increase in customers has come from the sales of ID.3 in the debut year.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

Trending Stories